Pfizer sought permission to import the vaccine distribution in India

New Delhi, 6th Dec: One of the world’s premier biopharmaceutical companies, Pfizer India has sought COVID-19 vaccine authorization.

News source said that the firm application submitted to the drug regulator, has sought permission to import the vaccine for sale and distribution in India on December 4.

Pfizer India has become the first pharmaceutical firm to seek from the Drugs Controller General of India an emergency use authorisation for its COVID-19 vaccine in the country, after its parent company secured such clearance in the UK and Bahrain.

Times of India reported that at an all-party meeting recently, Prime Minister Narendra Modi said a Covid-19 vaccine is expected to be ready in the next few weeks, and as soon as scientists give a green signal, vaccination will start in India.

Meanwhile, India recorded 36,011 new Covid-19 infections in the last 24 hours, the Union Ministry of Health and Family Welfare said on Sunday. The overall Covid-19 cases in India reached 96,44,222, including 4,03,248 active cases and 91,00,792 recoveries. With 482 new deaths, the cumulative toll mounted to 1,40,182.